Snoval Pharmaceuticals Pvt Ltd

Snoval Pharmaceuticals Pvt Ltd - fmcg in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH1983PTC029344 Incorporated 18 February 1983 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company FMCG
Data last updated
Revenue · FY 2024
₹15.4 Lakh
▲ 3% YoY
Net profit · FY 2024
₹8.82 Lakh
Net margin 57.3%
EBITDA · FY 2024
₹13.92 Lakh
EBITDA margin 90.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹4 Lakh
Issued & subscribed
Open charges
₹18.75 Cr
Secured borrowings
Company age
43 yrs
Est. 1983
Directors on board
4
As per MCA filings

About Snoval Pharmaceuticals Pvt Ltd

Data last updated:

Snoval Pharmaceuticals Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ecokrin Hygiene Private Limited. It operates in the cosmetics and makeup products segment of the FMCG sector. It was incorporated on 18 February 1983 and has been in existence for over 43 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1983PTC029344. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Pallavi Kirtikumar Lakdawala and Rakesh Mahendra Lakdawala.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 77/4 Lakdi Bunder Darukhana, Mumbai, Maharashtra, India – 400010.

As per the financials filed for FY 2024, the company reported a revenue of ₹15.4 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹8.82 Lakh (net margin 57.3%) and EBITDA of ₹13.92 Lakh (EBITDA margin 90.4%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 4% over five years.

As per MCA filings, the company has open charges of ₹18.75 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Snoval Pharmaceuticals Pvt Ltd
CIN U24239MH1983PTC029344
Registration Number 029344
Incorporation Date 18 February 1983
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Ecokrin Hygiene Private Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No 77/4 Lakdi Bunder Darukhana, Mumbai, Maharashtra, India – 400010
  • Industry
    FMCG, Cosmetics & Makeup Products
Comprehensive company report
Snoval Pharmaceuticals Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Snoval Pharmaceuticals Pvt Ltd report

Financials, compliance, directors, charges, ownership and filings for Snoval Pharmaceuticals Pvt Ltd in one report.

Financials from 2015 Directors & ownership Charges & compliance

Financials of Snoval Pharmaceuticals Pvt Ltd FY 2024 filings available

Snoval Pharmaceuticals Pvt Ltd reported revenue of ₹15.4 Lakh (up 3% YoY) for FY 2024.

Revenue · FY 2024
₹15.4 Lakh ▲ 3%
Net profit · FY 2024
₹8.82 Lakh margin 57.3%
EBITDA · FY 2024
₹13.92 Lakh margin 90.4%

Compounded Annual Growth Rate (CAGR) of Snoval Pharmaceuticals Pvt Ltd

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 1%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 1%

Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Snoval Pharmaceuticals Pvt Ltd

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹13.92 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹8.82 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Snoval Pharmaceuticals Pvt Ltd

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin90.4%••••••••••••••••
Net Profit Margin57.3%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Snoval Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Snoval Pharmaceuticals Pvt Ltd

Snoval Pharmaceuticals Pvt Ltd is compared with the companies closest to it by revenue in the FMCG industry (Colour Cosmetics, Formulations, Pharmaceuticals). Revenue, net profit, margin and growth of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Iffat Pharmaceuticals Private Limited••••••••••••••••-Mumbai, Maharashtra, India
Diar Pharmaceuticals Private Limited••••••••••••••••-New Delhi, Delhi, India
The Ethical Pharmaceutical Co. Private Limited••••••••••••••••-Mumbai, Maharashtra, India
Drhealth Pharmaceuticals Private Limited••••••••••••••••-Palghar West, Maharashtra, India
Magadh Pharmaceuticals Private Limited••••••••••••••••-Patna, Bihar, India
Snoval Pharmaceuticals Pvt Ltd this company••••••••••••••••-Mumbai, Maharashtra, India
Originia Pharmaceuticals Private Limited••••••••••••••••-Baramati, Maharashtra, India
Ybrex Pharmaceuticals Private Limited••••••••••••••••-Basai Road, Haryana, India
Vsirah Pharmaceuticals Private Limited••••••••••••••••-Pondicherry, India
Icines Pharmaceuticals Private Limited••••••••••••••••-Saharanpur, Uttar Pradesh, India
Citadel Fine Pharmaceuticals Private Limited••••••••••••••••-Madras-42., Tamil Nadu, India

Peers are the five companies nearest above and the five nearest below Snoval Pharmaceuticals by revenue in the FMCG industry (Colour Cosmetics, Formulations, Pharmaceuticals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.

Auditor Details of Snoval Pharmaceuticals Pvt Ltd

Snoval Pharmaceuticals Pvt Ltd is audited by BHAVIN SHAH ASSOCIATES for the financial year 2022.

NameStatusAppointment DateCessation Date
BHAVIN SHAH ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Snoval Pharmaceuticals Pvt Ltd

Snoval Pharmaceuticals has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Pallavi Kirtikumar LakdawalaDirector01 Jan 199927 Years 9 MonthsCurrent
Rakesh Mahendra LakdawalaDirector01 Jan 199927 Years 9 MonthsCurrent
Kirtikumar Manilal LakdawalaDirector18 Jul 199531 Years 2 MonthsCurrent
Jignesh Mahendra LakdawalaDirector01 Jan 199927 Years 9 MonthsCurrent

Ownership and Shareholding of Snoval Pharmaceuticals Pvt Ltd

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Snoval Pharmaceuticals Pvt Ltd

Open charges
₹18.75 Cr
Satisfied charges
None
Breakdown by lending institutions
Union Bank of India₹12.75 Cr
Hdfc Bank Limited₹6.00 Cr
Latest charge details
DateLenderAmountStatus
19 Jan 2022Hdfc Bank Limited₹6 CrOpen
28 Jul 2004Union Bank of India₹12.75 CrOpen

Total charge records: 2 View all charges

Employees and EPFO Compliance at Snoval Pharmaceuticals Pvt Ltd

Employment history and EPFO contributions of people linked to Snoval Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Snoval Pharmaceuticals Pvt Ltd

Snoval Pharmaceuticals Pvt Ltd has 4 board changes on record since 1995: 4 appointments. The latest: Jignesh Mahendra Lakdawala was appointed as Director on 01 Jan 1999.

AGM
Snoval Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Snoval Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 600.00 Lakh with Charge ID 100529787 was registered on 19 Jan 2022.
Charges
A charge with Union Bank Of India of Rs. 1,275.00 Lakh registered on 28 Jul 2004 with Charge ID 90165555 was modified on 02 Aug 2013.
Charges
A charge with Union Bank Of India amounted to Rs. 1,275.00 Lakh with Charge ID 90165555 was registered on 28 Jul 2004.
Appointed
Jignesh Mahendra Lakdawala was appointed as Director.
Appointed
Pallavi Kirtikumar Lakdawala was appointed as Director.
Appointed
Rakesh Mahendra Lakdawala was appointed as Director.
Appointed
Kirtikumar Manilal Lakdawala was appointed as Director.
Incorporation
18 Feb 1983
Snoval Pharmaceuticals Pvt Ltd was registered on 18 Feb 1983 with Roc Mumbai & aged 43 years 7 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Snoval Pharmaceuticals Pvt Ltd

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Snoval Pharmaceuticals Pvt Ltd

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Snoval Pharmaceuticals Pvt Ltd

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Snoval Pharmaceuticals Pvt Ltd

Snoval Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Snoval Pharmaceuticals Pvt Ltd

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Snoval Pharmaceuticals Pvt Ltd

Snoval Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in cosmetics and makeup products, within the FMCG industry. It was incorporated on 18 February 1983 (43+ years old) and is registered under CIN U24239MH1983PTC029344.

Snoval Pharmaceuticals reported revenue of ₹15.4 Lakh for FY 2024 (up 3% YoY).

Snoval Pharmaceuticals has 4 current directors:

Snoval Pharmaceuticals reported a net profit of ₹8.82 Lakh (net margin 57.3%) and EBITDA of ₹13.92 Lakh (EBITDA margin 90.4%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Snoval Pharmaceuticals is 1% over three years and -4% over five years. In the latest year (FY 2024) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.

No. Snoval Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Snoval Pharmaceuticals is U24239MH1983PTC029344. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Snoval Pharmaceuticals was incorporated on 18 February 1983, making it 43+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Snoval Pharmaceuticals by revenue are Iffat Pharmaceuticals Private Limited, Diar Pharmaceuticals Private Limited, The Ethical Pharmaceutical Co. Private Limited, Drhealth Pharmaceuticals Private Limited, Magadh Pharmaceuticals Private Limited and 5 more, all in the FMCG industry (Colour Cosmetics, Formulations, Pharmaceuticals).

Jignesh Mahendra Lakdawala was appointed as Director on 01 Jan 1999. Pallavi Kirtikumar Lakdawala was appointed as Director on 01 Jan 1999. Rakesh Mahendra Lakdawala was appointed as Director on 01 Jan 1999. Snoval Pharmaceuticals has 4 board changes on record in total.

The registered office of Snoval Pharmaceuticals is at Plot No 774 Lakdi Bunder Darukhana, Mumbai, Maharashtra, India – 400010.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available